Follow
Ondrej Hrusak
Ondrej Hrusak
2nd faculty of medicine, Charles University, Motol, Prague
Verified email at lfmotol.cuni.cz
Title
Cited by
Cited by
Year
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
JJM Van Dongen, L Lhermitte, S Böttcher, J Almeida, ...
Leukemia 26 (9), 1908-1975, 2012
10272012
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
T Kalina, J Flores-Montero, VHJ Van Der Velden, M Martin-Ayuso, ...
Leukemia 26 (9), 1986-2010, 2012
8092012
Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002
J Stary, M Zimmermann, M Campbell, L Castillo, E Dibar, S Donska, ...
American Society of Clinical Oncology, 2014
3902014
Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia
P Theunissen, E Mejstrikova, L Sedek, AJ van der Sluijs-Gelling, G Gaipa, ...
Blood, The Journal of the American Society of Hematology 129 (3), 347-357, 2017
3792017
The genetic basis and cell of origin of mixed phenotype acute leukaemia
TB Alexander, Z Gu, I Iacobucci, K Dickerson, JK Choi, B Xu, ...
Nature 562 (7727), 373-379, 2018
2852018
Antigen expression patterns reflecting genotype of acute leukemias
O Hrušák, A Porwit-MacDonald
Leukemia 16 (7), 1233-1258, 2002
2532002
Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment
O Hrusak, T Kalina, J Wolf, A Balduzzi, M Provenzi, C Rizzari, S Rives, ...
European Journal of Cancer 132, 11-16, 2020
2182020
Effect of blinatumomab vs chemotherapy on event-free survival among children with high-risk first-relapse B-cell acute lymphoblastic leukemia: a randomized clinical trial
F Locatelli, G Zugmaier, C Rizzari, JD Morris, B Gruhn, T Klingebiel, ...
Jama 325 (9), 843-854, 2021
2122021
Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group
C Langebrake, U Creutzig, M Dworzak, O Hrusak, E Mejstrikova, ...
Journal of Clinical Oncology 24 (22), 3686-3692, 2006
1702006
Quality assessment program for E uro F low protocols: Summary results of four‐year (2010–2013) quality assurance rounds
T Kalina, J Flores‐Montero, Q Lecrevisse, CE Pedreira, ...
Cytometry Part A 87 (2), 145-156, 2015
1582015
Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by …
J Trka, M Kalinova, O Hrušák, J Zuna, O Krejčí, J Madžo, P Sedláček, ...
Leukemia 16 (7), 1381-1389, 2002
1482002
AIEOP‐BFM consensus guidelines 2016 for flow cytometric immunophenotyping of pediatric acute lymphoblastic leukemia
MN Dworzak, B Buldini, G Gaipa, R Ratei, O Hrusak, D Luria, E Rosenthal, ...
Cytometry Part B: Clinical Cytometry 94 (1), 82-93, 2018
1362018
CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment
E Mejstríková, O Hrusak, MJ Borowitz, JA Whitlock, B Brethon, TM Trippett, ...
Blood cancer journal 7 (12), 659, 2017
1292017
Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study
S Mukkada, N Bhakta, GL Chantada, Y Chen, Y Vedaraju, L Faughnan, ...
The Lancet Oncology 22 (10), 1416-1426, 2021
1142021
Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?
E Fronkova, E Mejstrikova, S Avigad, KW Chik, L Castillo, S Manor, ...
Leukemia 22 (5), 989-997, 2008
992008
Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort
M Zaliova, J Stuchly, L Winkowska, A Musilova, K Fiser, M Slamova, ...
Haematologica 104 (7), 1396, 2019
962019
TEL/AML1 positivity in childhood ALL: average or better prognosis?
J Zuna, O Hrušák, M Kalinova, K Mužíková, J Starý, J Trka
Leukemia 13 (1), 22-24, 1999
961999
ETV6/RUNX1 (TEL/AML1) is a frequent prenatal first hit in childhood leukemia
J Zuna, J Madzo, O Krejci, Z Zemanova, M Kalinova, K Muzikova, ...
Blood, The Journal of the American Society of Hematology 117 (1), 368-369, 2011
902011
Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria
E Mejstrikova, J Volejnikova, E Fronkova, K Zdrahalova, T Kalina, ...
Haematologica 95 (6), 928, 2010
872010
International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia
O Hrusak, V De Haas, J Stancikova, B Vakrmanova, I Janotova, ...
Blood, The Journal of the American Society of Hematology 132 (3), 264-276, 2018
842018
The system can't perform the operation now. Try again later.
Articles 1–20